It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The aim of the study was an ultrasound assessment of distal interphalangeal (DIP) joint enthesopathy in patients with nail psoriasis. Altogether, 72 patients with nail psoriasis (41 with psoriasis and 31 with psoriatic arthritis) and 30 people in the control group participated in the study. In total, 1014 nails were examined. The thickness of DIP digital extensor tendons in the groups of patients with psoriasis (Ps) and psoriatic arthritis (PsA) was correlated with the nail bed thickness (r = 0.316, p = 0.027 vs. r = 0.402, p = 0.031, respectively) and with the thickness of the nail matrix in patients with psoriasis (r = 0.421, p = 0.012). The linear regression model showed the tendon thickness in Ps patients to be affected by the nail bed thickness, duration of psoriasis and the thickness of the nail matrix, whereas in PsA patients it was found to be significantly affected by duration of psoriasis and of arthritis, the nail bed thickness, CRP concentration and the swollen joint count. Our findings may indicate the role of the nail-tendon apparatus changes in the PsA development and they emphasise the justifiability of US examinations in patients with psoriasis direct assessment of morphological changes in nails as potential predictors of PsA development.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Municipal Hospital in Olsztyn, Department of Rheumatology, Olsztyn, Poland; University of Warmia and Mazury, Department of Internal Medicine, School of Medicine, Collegium Medicum, Olsztyn, Poland (GRID:grid.412607.6) (ISNI:0000 0001 2149 6795); University of Warmia and Mazury, Department of Pathophysiology, School of Medicine, Collegium Medicum, Olsztyn, Poland (GRID:grid.412607.6) (ISNI:0000 0001 2149 6795)
2 University of Warmia and Mazury, Department of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, School of Medicine, Collegium Medicum, Olsztyn, Poland (GRID:grid.412607.6) (ISNI:0000 0001 2149 6795)
3 Faculty of Earth Sciences, Department of Geomatics and Cartography Nicolaus Copernicus University, Torun, Poland (GRID:grid.5374.5) (ISNI:0000 0001 0943 6490); DRAMIŃSKI S.A. Ultrasound Scanners, Olsztyn, Poland (GRID:grid.5374.5)
4 DRAMIŃSKI S.A. Ultrasound Scanners, Olsztyn, Poland (GRID:grid.5374.5)
5 University of Warmia and Mazury, Department of Pathophysiology, School of Medicine, Collegium Medicum, Olsztyn, Poland (GRID:grid.412607.6) (ISNI:0000 0001 2149 6795); School of Medicine, Collegium Medicum, University of Warmia and Mazury, Laboratory for Regenerative Medicine, 10-900, Olsztyn, Poland (GRID:grid.412607.6) (ISNI:0000 0001 2149 6795)